Patented precision fermentation for peptide production
A sophisticated precision fermentation platform specializing in the production of peptides and proteins using yeast, with a proven track record and readiness for large-scale operations.
Overview
Patented precision fermentation technology offers a robust platform for the production of peptides and proteins utilizing yeast. With over 20 years of experience in the field, this technology allows for the manufacturing of peptides with sequences ranging from 2 to 3,400 amino acids. It is a highly versatile solution capable of producing almost any peptide or protein given the appropriate amino acid sequence. The technology is well-suited for applications across pharmaceuticals, biotechnology, and specialty chemicals.
Technical specifications
- Vessel capacity: Current fermentation operations are conducted in 2-ton vessels, with plans to expand capabilities to 60-ton vessels or larger.
- Scope of production: Capable of producing over 500 types of peptides, accommodating a wide range of amino acid sequences.
- Production process: After receiving the amino acid sequence, the peptide is manufactured, with discussions on delivery results, quantities, and formats to ensure it meets client specifications.
Technology readiness level
This precision fermentation technology is at Technology Readiness Level 7, indicating that it has been demonstrated in operational environments and is ready for scaling up and commercial deployment in larger production facilities.
About 2D LLC
CopX is a United States-based corporation focused on biotechnology and wellness products, including functional proteins, exosome preparations, and healthspan monitoring technologies. The company utilizes precision fermentation to produce proteins at scale, drawing on international research expertise to develop products aimed at supporting cellular function and mitigating age-related decline. Their portfolio includes 2D Functional Proteins, which are targeted blends designed to replenish essential peptides, and 2D Exomax, an exosome preparation derived from human umbilical cord mesenchymal stem cells for regenerative science applications. The company also promotes the 2DHeal network, which integrates health assessments such as AI-powered retinal imaging—using Airdoc camera technology—with their product offerings to provide personalized wellness insights.
By leveraging advanced manufacturing and diagnostic tools, CopX aims to support professional and research applications in health and integrative medicine. The company maintains international operational facilities for manufacturing and research, emphasizing scalability and sustainable production methods. Their model involves providing high-quality biological materials and screening services to health professionals and partners worldwide, focusing on addressing chronic inflammatory and degenerative health challenges. Through strategic collaborations and a emphasis on continuous production, CopX seeks to facilitate advancements in areas ranging from alternative proteins to biopharmaceuticals and personalized anti-aging protocols.
Inquire about this partnering listing
Industry applications
delivered to your inbox.